PMS2 and colorectal carcinoma: In contrast, the cumulative incidence of CRC was 0.9%–4.5% for MLH1, 0.7%–2.6% for MSH2/EPCAM, 0%–0.5% for MSH6, and 0.2%–0.4% for PMS2 in males.